Recent Updates
Recently added Catalysts

Biotech M&A Tracker

Track biopharma mergers, acquisitions, and predicted takeover targets with deal premiums and therapeutic area analysis.
$942BIndustry FirepowerEY 2026
$136B → $370BGrowth Gap by 2028 (2032)EY Firepower
21Deals YTD
26%Avg Premium
$240B2025 M&A Value

This Week's Movers

last 7 days
  • INCY59 12 pts
    Acquirer Demand
  • AMLX49 11 pts
    Pipeline Attractiveness
  • MD35 6 pts
    Fundamental Valuation
  • DCTH56 5 pts
    Acquirer Demand
  • NUVL62 5 pts
    Acquirer Demand

Acquirer Urgency Heatmap

click to drill down
  • MRKMerck10/10
  • BMYBristol-Myers Squibb10/10
  • PFEPfizer8/10
  • BIIBBiogen6/10
  • AMGNAmgen7/10
  • GILDGilead Sciences7/10
  • AZNAstraZeneca6/10
  • NVSNovartis6/10

Recent Deals

latest 5
  • Jun 24Announced
    Terns Pharmaceuticals, Inc.←Merck & Co., Inc.
    $6.7Boncology
  • Jun 17Announced
    Verona Pharma plc←Merck & Co., Inc.
    $10.0B+23% premrespiratory
  • May 20Announced
    Engage Biologics←Eli Lilly and Company
    $202Mdrug delivery
  • May 6Announced
    PathAI, Inc.←Roche Holding AG
    $1.5Bdiagnostics
  • Apr 27Announced
    Ajax Therapeutics, Inc.←Eli Lilly and Company
    $2.3Boncology

Top 10 Targets — Probability Leaderboard

#TickerCompanyScoreTierTop Acquirer MatchLead Asset
1SNDX72HIGHMRKAZNBMY—
2TARA68HIGHREGNBMYJNJ—
3AVBP67HIGHREGNJNJNVS—
4ZYME65HIGHJNJNVSAMGN—
5ACHV65HIGHABBVREGNMRK—